Astera Labs (NASDAQ:ALAB) Director Stefan Dyckerhoff Sells 8,994 Shares of Stock

Astera Labs, Inc. (NASDAQ:ALAB) Director Stefan Dyckerhoff sold 8,994 shares of the stock in a transaction dated Wednesday, October 7th. The stock was sold at an average price of $376.06, for a total value of $3,382,283.64. Following the sale, the director directly owned 2,648 shares in the company, valued at $995,806.88. This trade represents a 77.25% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs Price Performance

ALAB stock traded down $4.84 during mid-day trading on Friday, reaching $342.21. 4,063,848 shares of the company traded hands, compared to its average volume of 5,191,571. The company has a market capitalization of $59.37 billion, a P/E ratio of 169.41 and a beta of 3.68. Astera Labs, Inc. has a 52-week low of $97.89 and a 52-week high of $499.48. The company has a fifty day moving average price of $316.82 and a 200-day moving average price of $290.03.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The firm had revenue of $392.40 million for the quarter, compared to the consensus estimate of $360.85 million. During the same period in the prior year, the firm posted $0.44 earnings per share. The company’s revenue for the quarter was up 104.5% on a year-over-year basis. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. As a group, analysts forecast that Astera Labs, Inc. will post 2.7 EPS for the current year.

Analyst Upgrades and Downgrades

A number of research firms have recently commented on ALAB. Weiss Ratings upgraded shares of Astera Labs from a “hold (c)” rating to a “buy (b-)” rating in a research report on Thursday. Needham & Company LLC increased their price objective on Astera Labs from $260.00 to $425.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. Susquehanna lifted their price objective on Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research note on Friday, July 31st. UBS Group reiterated a “neutral” rating and set a $425.00 price target on shares of Astera Labs in a research report on Wednesday, August 5th. Finally, Jefferies Financial Group boosted their price objective on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a report on Wednesday, August 5th. Eleven analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to data from MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and an average price target of $348.33.

Hedge Funds Weigh In On Astera Labs

Hedge funds and other institutional investors have recently modified their holdings of the company. Reflection Asset Management bought a new position in shares of Astera Labs during the 4th quarter valued at about $25,000. Keating Financial Advisory Services Inc. bought a new stake in Astera Labs in the 2nd quarter worth approximately $25,000. GK Wealth Management LLC purchased a new stake in Astera Labs in the third quarter worth approximately $29,000. Archer Investment Corp bought a new position in Astera Labs during the second quarter valued at approximately $30,000. Finally, Whipplewood Advisors LLC grew its position in Astera Labs by 15,950.0% during the first quarter. Whipplewood Advisors LLC now owns 321 shares of the company’s stock valued at $35,000 after acquiring an additional 319 shares during the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Astera Labs News Summary

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Astera Labs introduced Aries 7, described as the industry’s first PCIe 7 signal-conditioning portfolio spanning copper and optical interconnects. The lineup includes retimers, redrivers, cable modules, optical drivers and optical transimpedance amplifiers, positioning the company to benefit from expanding AI infrastructure and higher-speed data-center connectivity. Astera Labs Announces Aries 7
• Positive Sentiment: Marvell’s projection that connecting AI chips could become a $37 billion business reinforced investor optimism about the broader AI-connectivity market and helped highlight Astera’s growth opportunity. However, the companies discussed in the coverage remain dependent on major customers. Marvell AI Connectivity Market Forecast
• Neutral Sentiment: Analysts and market coverage are comparing Astera’s role in connecting AI racks with Micron’s memory and system exposure. Astera offers substantial growth potential, but competition from Marvell and Credo is intensifying. Micron Versus Astera Labs
• Negative Sentiment: Northland Securities downgraded ALAB from “outperform” to “market perform,” adding pressure to the shares and signaling that the current valuation may already reflect substantial AI-related growth. Northland Securities Downgrade
• Negative Sentiment: Jim Cramer praised Astera’s business but criticized its price, reinforcing concerns that the stock’s valuation leaves limited room for execution mistakes or slower growth. Jim Cramer Discusses Astera Labs Valuation

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.